William A. Faubion, M.D., is a consultant in the Division of Gastroenterology, Department of Internal Medicine at Mayo Clinic in Arizona, where he also serves as dean for research. Dr. Faubion joined the staff of Mayo Clinic in 1999 and holds the academic rank of professor of immunology, medicine and pediatrics, the Mayo Clinic College of Medicine and Science.
Dr. Faubion earned his B.A. from Dartmouth College and his M.D. from the University of Texas Health Science Center Medical School. He completed a residency in internal medicine/pediatrics at Texas Medical Center at the University of Texas and a fellowship in pediatric and adult gastroenterology at Mayo Clinic.
He also trained as a gastrointestinal fellow at the Center for Basic Research in Digestive Diseases at Mayo Clinic. Dr. Faubion served as a major in the 133rd Airlift Wing in the United States Air Force.
Dr. Faubion has a focused interest in pediatric and adult inflammatory bowel disease, and his research centers on examining how immune cells make “fate decisions” to become pro-inflammatory and cause the chronic intestinal inflammation of IBD. His extensive clinical research studies have evaluated the efficacy of novel therapeutics (including cell therapies) in adult and pediatric onset Crohn’s disease and ulcerative colitis as well as novel biomarkers predictive of active and complicated IBD. Funding for his projects has come from the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute of Allergy and Immunology, the Crohn’s & Colitis Foundation of America, the Leona Helmsley Foundation, Connecticut Children’s Medical Center, Oberkotter Foundation, the Bill and Melinda Gates Foundation, and industry partners.